Risk Factors for Residual Disease in Hysterectomy Specimens After Conization in Post-Menopausal Patients with Cervical Intraepithelial Neoplasia Grade 3

References

• Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO, Keep SL. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev. 2010;6.
   Google Scholar
• Simoes RB, Campaner AB. Post-cervical conization outcomes in patients with high-grade intraepithelial lesions. APMIS. 2013;121(12):1153–1161. doi:10.1111/apm.1206423607318
   PubMed Web of Science ®Google Scholar
• Baloglu A, Uysal D, Bezircioglu I, Bicer M, Inci A. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions. Arch Gynecol Obstet. 2010;282(1):69–73. doi:10.1007/s00404-009-1298-319940997
   PubMed Web of Science ®Google Scholar
• Melnikow J, McGahan C, Sawaya GF, et al. Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst. 2009;101(10):721–728. doi:10.1093/jnci/djp08919436026
   PubMedGoogle Scholar
• Kang WD, Kim SM. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women. Menopause. 2016;23(1):81–86. doi:10.1097/GME.000000000000048826057824
   PubMed Web of Science ®Google Scholar
• Katki HA, Schiffman M, Castle PE, et al. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. J Low Genit Tract Dis. 2013;17:S78–84. doi:10.1097/LGT.0b013e31828543c523519309
   PubMed Web of Science ®Google Scholar
• Kocken M, Helmerhorst TJ, Berkhof J, et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. Lancet Oncol. 2011;12(5):441–450. doi:10.1016/S1470-2045(11)70078-X21530398
   PubMed Web of Science ®Google Scholar
• Alonso I, Torne A, Puig-Tintore LM, et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol. 2006;103(2):631–636. doi:10.1016/j.ygyno.2006.04.01616780934
   PubMed Web of Science ®Google Scholar
• Del Mistro A, Matteucci M, Insacco EA, et al. Long-term clinical outcome after treatment for high-grade cervical lesions: a retrospective monoinstitutional cohort study. Biomed Res Int. 2015;2015:1–8. doi:10.1155/2015/984528
   Web of Science ®Google Scholar
• Leguevaque P, Motton S, Decharme A, et al. Predictors of recurrence in high-grade cervical lesions and a plan of management. Eur J Surg Oncol. 2010;36(11):1073–1079. doi:10.1016/j.ejso.2010.08.13520870375
   PubMed Web of Science ®Google Scholar
• Lili E, Chatzistamatiou K, Kalpaktsidou-Vakiani A, et al. Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up. Medicine. 2018;97(4):e9719. doi:10.1097/MD.000000000000971929369205
   PubMed Web of Science ®Google Scholar
• Brown JV, Peters WA, Corwin DJ. Invasive carcinoma after cone biopsy for cervical intraepithelial neoplasia. Gynecol Oncol. 1991;40(1):25–28. doi:10.1016/0090-8258(91)90079-K1989911
   PubMed Web of Science ®Google Scholar
• Jing L, Dan W, Zhunan L, et al. Residual lesions in uterine specimens after loop electrosurgical excision procedure in patients with CIN. Arch Gynecol Obstet. 2018;298(4):805–812. doi:10.1007/s00404-018-4881-730167855
   PubMed Web of Science ®Google Scholar
• Ayhan A, Tuncer Hasan A, Reyhan NH, et al. Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins. Eur J Obstet Gynecol Reprod Biol. 2016;201:1–6. doi:10.1016/j.ejogrb.2016.03.02127038228
   PubMed Web of Science ®Google Scholar
• Swift Brenna E, Wang L, Jembere N, et al. Risk of recurrence after treatment for cervical intraepithelial neoplasia 3 and adenocarcinoma in situ of the cervix: recurrence of CIN 3 and AIS of cervix. J Low Genit Tract Dis. 2020;24(3):252–258.32384365
   PubMed Web of Science ®Google Scholar
• Tasci T, Turan T, Ureyen I, et al. Is there any predictor for residual disease after cervical conization with positive surgical margins for HSIL or microinvasive cervical cancer? J Low Genit Tract Dis. 2015;19:115–118. doi:10.1097/LGT.000000000000007925259663
   PubMed Web of Science ®Google Scholar
• Bilibio JP, Monego HI, Binda MLA, et al. Menopausal status is associated with a high risk for residual disease after cervical conization with positive margins. PLoS One. 2019;14:e0217562. doi:10.1371/journal.pone.021756231163055
   PubMed Web of Science ®Google Scholar
• Bulten J, Horvat R, Jordan J, Herbert A, Wiener H, Arbyn M. European guidelines for quality assurance in cervical histopathology. Acta Oncol. 2011;50(5):611–620. doi:10.3109/0284186X.2011.55577921314297
   PubMed Web of Science ®Google Scholar
• Diaz ES, Aoyama C, Baquing MA, et al. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins. Gynecol Oncol. 2014;132(1):76–80. doi:10.1016/j.ygyno.2013.11.01924262876
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim KR, Mok JE, et al. Pathologic risk factors for predicting residual disease in subsequent hysterectomy following LEEP conization. Gynecol Oncol. 2007;105(2):434–438.17303228
   PubMed Web of Science ®Google Scholar
• Arbyn M, Redman C, Verdoodt F, et al. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncol. 2017;18:1665–1679. doi:10.1016/S1470-2045(17)30700-329126708
   PubMed Web of Science ®Google Scholar
• Serati M, Siesto G, Carollo S, et al. Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study. Eur J Obstet Gynecol Reprod Biol. 2012;165(1):86–90. doi:10.1016/j.ejogrb.2012.06.02622771223
   PubMed Web of Science ®Google Scholar